Prolia and Gravol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prolia (denosumab) and Gravol (dimenhydrinate). Common drug interactions include rheumatoid arthritis among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Prolia and Gravol. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Prolia?

Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,389 Prolia users. Check the latest studies of Prolia.

What is Gravol?

Gravol has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 7,193 Gravol users. Check the latest studies of Gravol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

45 people who take Prolia and Gravol together, and have interactions are studied.

Prolia and Gravol drug interactions.

What are the common drug interactions of Prolia and Gravol, by gender? *:

female:

  1. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  2. Weight increased
  3. Cough
  4. Joint injury
  5. Joint swelling
  6. Productive cough
  7. Hypotension (abnormally low blood pressure)
  8. Arthropathy
  9. Asthma
  10. Blood pressure diastolic decreased

male:

  1. Dizziness
  2. Fatigue (feeling of tiredness)
  3. Headache (pain in head)
  4. Irritable bowel syndrome
  5. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Prolia and Gravol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Balance disorder
  2. Blood pressure fluctuation
  3. Blood pressure increased
  4. C-reactive protein increased
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Dysstasia (difficulty in standing)
  7. Feeding disorder (when children refuse to eat certain food groups)
  8. Haematuria (presence of blood in urine)
  9. Joint injury
  10. Limb injury

40-49:

n/a

50-59:

  1. Drug intolerance (drug sensitivity)
  2. Erythema (redness of the skin)
  3. Fatigue (feeling of tiredness)
  4. Haemorrhage (bleeding)
  5. Hypotension (abnormally low blood pressure)
  6. Joint injury
  7. Joint swelling
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  10. Nasopharyngitis (inflammation of the nasopharynx)

60+:

  1. Fatigue (feeling of tiredness)
  2. Diarrhoea
  3. Arthralgia (joint pain)
  4. Intestinal obstruction
  5. Stress
  6. Anaemia (lack of blood)
  7. Drug ineffective
  8. Platelet count decreased
  9. Dizziness
  10. Blood urine present

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 21 people, 46.67%
  2. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 9 people, 20.00%
  3. Vasculitis (inflammation of a blood vessel or blood vessels): 4 people, 8.89%
  4. Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 4 people, 8.89%
  5. Pain: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Prolia and Gravol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prolia and Gravol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gravol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gravol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on denosumab and dimenhydrinate (the active ingredients of Prolia and Gravol, respectively), and Prolia and Gravol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: